Phathom Pharmaceuticals
PHAT
PHAT
87 hedge funds and large institutions have $317M invested in Phathom Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
87
Holders Change
-7
Holders Change %
-7.45%
% of All Funds
1.4%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
30
Reduced
25
Closed
15
Calls
$133K
Puts
$124K
Net Calls
+$9K
Net Calls Change
-$1.91M
Top Buyers
| 1 |
OM
1
Opaleye Management
Boston,
Massachusetts
|
$4.68M |
| 2 |
NM
2
Newtyn Management
New York
|
$5.43M |
| 3 |
3
BlackRock
New York
|
$19M |
| 4 |
4
Walleye Capital
New York
|
$1.64M |
| 5 |
5
Invesco
Atlanta,
Georgia
|
$24.8M |
Top Sellers
| 1 |
DM
1
Deerfield Management
New York
|
$0 |
| 2 |
6CM
2
683 Capital Management
New York
|
$15.1M |
| 3 |
UOC
3
UBS O'Connor
Chicago,
Illinois
|
$0 |
| 4 |
HF
4
HRT Financial
New York
|
$0 |
| 5 |
5
Millennium Management
New York
|
$0 |
